Heterocyclic compounds for the inhibition of pask

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10953012
APP PUB NO 20120277224A1
SERIAL NO

13456838

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed herein are new heterocyclic compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibiting PAS Kinase (PASK) activity in a human or animal subject are also provided for the treatment of diseases such as diabetes mellitus.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BIOENERGENIX LLC1700 OWENS STREET SAN FRANCISCO CA 94158

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kelly, Robert C San Francisco, US 46 350
McCall, John M Boca Grande, US 93 846
Romero, Donna L Chesterfield, US 69 752

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 23, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 23, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00